NR4A1 and breast carcinoma: Nur77, a tumor suppressor, inhibits breast cancer cells from uptaking exogenous fatty acids and blocks the accumulation of fatty acids in the tumor metabolic microenvironment by inhibiting the transcription of the transmembrane protein CD36 and the cytoplasmic fatty acid-binding protein FABP4.